San Luis Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,089
+28
+3% +$28.6K 0.2% 74
2026
Q1
$976K Sell
1,061
-18
-2% -$18.2K 0.16% 92
2025
Q4
$1.16M Sell
1,079
-5
-0.5% -$4.78K 0.19% 71
2025
Q3
$827K Buy
1,084
+571
+111% +$425K 0.15% 87
2025
Q2
$400K Sell
513
-4,306
-89% -$3.35M 0.09% 111
2025
Q1
$3.98M Sell
4,819
-352
-7% -$293K 0.9% 30
2024
Q4
$3.99M Buy
5,171
+4,600
+806% +$3.81M 0.76% 37
2024
Q3
$506K Buy
571
+50
+10% +$45K 0.1% 94
2024
Q2
$472K Buy
+521
New +$417K 0.11% 72
2022
Q2
Sell
-405
Closed -$112K 276
2022
Q1
$112K Buy
+405
New +$104K 0.05% 190

Other funds holding LLY

San Luis Wealth Advisors's LLY Position: Q2 2026 in Review

San Luis Wealth Advisors increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $28.6K and bringing the position to 1,089 shares worth $1.31M. The position accounts for 0.2% of the portfolio, ranked #74.

San Luis Wealth Advisors first reported a position in LLY in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.99M in Q4 2024. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • San Luis Wealth Advisors held 1,089 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • San Luis Wealth Advisors bought 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.2% of San Luis Wealth Advisors's portfolio in Q2 2026, its #74 holding.
  • San Luis Wealth Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 10 quarters since.
  • San Luis Wealth Advisors's Eli Lilly position peaked at $3.99M in Q4 2024.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on San Luis Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.